Lilly opens biotech in San Diego
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
BIL also holds an option to increase its equity stake by an additional 15%
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
Pegozafermin offers a distinct mechanism of action with potential for enhanced efficacy and tolerability and opportunities for combination development with incretins
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Prior to this appointment, he served as Vice-Chancellor of Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur,
Subscribe To Our Newsletter & Stay Updated